Anti-OXCT1/SCOT antibody
5
(1 Review)
|
(9 Publications)
Rabbit Polyclonal OXCT1/SCOT antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Recombinant Fragment Protein within Human OXCT1 aa 150-450.
View Alternative Names
OXCT, SCOT, OXCT1, 3-oxoacid CoA-transferase 1, Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, Succinyl-CoA:3-oxoacid CoA transferase, SCOT-s
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OXCT1/SCOT antibody (AB105320)
ab105320 at 1/100 dilution staining OXCT1/SCOT in Human fetal kidney tissue
- WB
Unknown
Western blot - Anti-OXCT1/SCOT antibody (AB105320)
All lanes:
Western blot - Anti-OXCT1/SCOT antibody (ab105320) at 1/500 dilution
Lane 1:
Human fetal heart lysate
Lane 2:
Human fetal brain lysate
Predicted band size: 56 kDa
false
Reactivity data
Properties and storage information
Form
Reconstitution
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OXCT1 functions as an important enzyme in ketolysis which is the breakdown of ketone bodies for energy production. It does not operate within a large complex but interacts closely with other enzymes involved in similar metabolic processes. OXCT1 ensures that tissues efficiently convert ketone bodies like acetoacetate and beta-hydroxybutyrate into acetyl-CoA which then feeds into the citric acid cycle to fulfill energy requirements especially when carbohydrates are sparse.
Pathways
OXCT1 is an important component of the ketone body metabolism pathway linking it to energy homeostasis and ketogenesis. It directly interacts with enzymes like acetoacetyl-CoA thiolase and beta-hydroxybutyrate dehydrogenase. Through these associations it integrates into larger metabolic pathways such as the citric acid cycle which is essential for energy production under conditions when lipids become a primary source for energy generation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Proceedings of the National Academy of Sciences of the United States of America 119:e2203628119 PubMed36201541
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 10:e020729 PubMed34583524
2021
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:6559-6571 PubMed34559577
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroscience methods 334:108591 PubMed31926203
2020
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 14:e0210454 PubMed31034522
2019
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 15:427-438 PubMed30338499
2018
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Endocrinology and 312:E437-E446 PubMed28223292
2017
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 30:1976-86 PubMed26849960
2016
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Endocrinology and 304:E826-35 PubMed23423173
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com